The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars)
Cell therapy companies investment 2017-2021
This statistic depicts the investment of cell therapy biotech companies from 2017 to 2021 worldwide. Cell therapy investments increased dramatically over the given period, especially between 2019 and 2021.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Cell therapy studies being conducted globally as of 2018, by region
- Premium Statistic Number of active trials for cell and gene therapies worldwide 2022 by trial phase
- Basic Statistic Indications in clinical trials for cell and gene therapies worldwide 2022
- Basic Statistic U.S. and Europe's selected anti-CD19 Car-T therapy sales forecast 2024
- Premium Statistic Top companies based on CAR-T cancer therapy patents 2010-2021
- Premium Statistic U.S. average annual wages per employee by industry 2023
- Premium Statistic U.S. states with large employment in drugs and pharmaceuticals 2023
- Basic Statistic Expected top life science startups in the U.S. 2024-2025
- Basic Statistic Key indications in oncology pipeline worldwide 2023
- Basic Statistic Global ongoing regenerative medicine clinical trials by phase and sponsor Q2 2024
About the region
10
- Basic Statistic Drugs in R&D pipeline worldwide 2025-2026, by phase of development
- Premium Statistic ATMP clinical trials share globally by type of sponsor 2016
- Premium Statistic Market cap of select pharma companies with strong pipeline 2017
- Premium Statistic ATMP clinical trials non-commercial sponsors distribution globally 2016
- Premium Statistic ATMP trials classification share by disease and development phase globally 2016
- Premium Statistic Clinical trials initiated worldwide 2018-2024
- Basic Statistic Clinical trials initiated worldwide 2018-2024, by trial phase
- Basic Statistic Most impactful areas to clinical real-world evidence as of 2018
- Basic Statistic Employees at Sobi 2013-2024
- Basic Statistic Profit of Sobi 2009-2024
Selected statistics
10
- Premium Statistic Top global biotech companies — R&D expenditure 2024
- Basic Statistic Projected most valuable R&D projects based on net present value 2026
- Premium Statistic Major global biotech companies' selection based on market cap 2026
- Premium Statistic Biotechnology funding by National Institutes for Health 2013-2024
- Premium Statistic Projection of top orphan drugs by global revenue 2030
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Leading mRNA biotech companies' market cap 2026
- Premium Statistic Forecasted revenue of mRNA market revenue worldwide 2021-2035
- Basic Statistic Total number of biotechnology companies in Europe 2023
- Basic Statistic Global market size for regenerative medicine 2022-2032
Other regions
10
- Premium Statistic US and European private VC-backed orphan biopharma company M&A values 2014-2019
- Premium Statistic U.S. number of IPOs for neurology companies 2006-2024
- Basic Statistic Impact of U.S. biopharmaceutical industry on employment 2022
- Basic Statistic U.S. venture funding of therapeutic companies by disease type 2024
- Basic Statistic Share of life sciences employees in the UK in 2021, by region
- Basic Statistic Global distribution of blood plasma produced by region 2015
- Premium Statistic Size of U.S. CRO market 2024 vs. 2031
- Premium Statistic R&D expenditure of the major CROs in China 2017-2019
- Premium Statistic Revenue breakdown of the major CROs in China 2019, by segment
- Premium Statistic Employees in select life sciences sectors by leading US state 2016 vs. 2021
Related statistics
10
- Premium Statistic Preclinical CRO market share worldwide by company 2016
- Premium Statistic Top 10 global pharmaceutical companies by revenue 2025
- Basic Statistic Global volume of plasma produced for fractionation 1990-2018, by type
- Basic Statistic Average total number of patients per drug trial started worldwide 2012-2023
- Basic Statistic Clinical drug trials started worldwide 2018-2023, by key therapeutic area
- Basic Statistic Mechanism of action in oncology pipeline worldwide 2023
- Premium Statistic Mechanism of action in obesity R&D pipeline worldwide 2024
- Basic Statistic Average number of subjects per drug trial started worldwide 2015-2020, by phase
- Basic Statistic Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Premium Statistic Clinical phase Alzheimer’s disease drugs 2025, by sponsor
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Labiotech. (March 1, 2023). Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1377206/investment-in-cell-therapy-companies/
Labiotech. "Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars)." Chart. March 1, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1377206/investment-in-cell-therapy-companies/
Labiotech. (2023). Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1377206/investment-in-cell-therapy-companies/
Labiotech. "Investment in Cell Therapy Companies Worldwide from 2017 to 2021 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 1 Mar 2023, /statistics/1377206/investment-in-cell-therapy-companies/
Labiotech, Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1377206/investment-in-cell-therapy-companies/ (last visited July 29, 2026)
Investment in cell therapy companies worldwide from 2017 to 2021 (in billion U.S. dollars) [Graph], Labiotech, March 1, 2023. [Online]. Available: /statistics/1377206/investment-in-cell-therapy-companies/
Advertisement